FR2253531A1 - - Google Patents

Info

Publication number
FR2253531A1
FR2253531A1 FR7439877A FR7439877A FR2253531A1 FR 2253531 A1 FR2253531 A1 FR 2253531A1 FR 7439877 A FR7439877 A FR 7439877A FR 7439877 A FR7439877 A FR 7439877A FR 2253531 A1 FR2253531 A1 FR 2253531A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7439877A
Other languages
French (fr)
Other versions
FR2253531B1 (xx
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25713544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2253531(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CH1711173A external-priority patent/CH589716A5/de
Priority claimed from CH1404374A external-priority patent/CH603790A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2253531A1 publication Critical patent/FR2253531A1/fr
Application granted granted Critical
Publication of FR2253531B1 publication Critical patent/FR2253531B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/06—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/885—Trichoderma

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
FR7439877A 1973-12-06 1974-12-05 Expired FR2253531B1 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1711173A CH589716A5 (en) 1973-12-06 1973-12-06 Antibiotics S 7481-F-1 and 2 - prepd. from new strains of Cylindrocarbon or Trichoderma esp. useful as immunosuppressant
CH1404374A CH603790A5 (en) 1974-10-21 1974-10-21 Antibiotics S 7481-F-1 and 2

Publications (2)

Publication Number Publication Date
FR2253531A1 true FR2253531A1 (xx) 1975-07-04
FR2253531B1 FR2253531B1 (xx) 1978-07-21

Family

ID=25713544

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7439877A Expired FR2253531B1 (xx) 1973-12-06 1974-12-05

Country Status (19)

Country Link
JP (1) JPS5615235B2 (xx)
AU (1) AU500889B2 (xx)
CA (1) CA1030469A (xx)
DD (1) DD115695A5 (xx)
DE (2) DE2455859C2 (xx)
DK (1) DK136780B (xx)
ES (1) ES432559A1 (xx)
FI (2) FI52851C (xx)
FR (1) FR2253531B1 (xx)
GB (1) GB1491509A (xx)
HK (1) HK53880A (xx)
IE (1) IE40549B1 (xx)
IL (1) IL46180A (xx)
MY (1) MY8100203A (xx)
NL (1) NL179220C (xx)
NO (1) NO744292L (xx)
NZ (1) NZ176117A (xx)
PH (1) PH13773A (xx)
SE (1) SE423720B (xx)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2338251A1 (fr) * 1975-11-04 1977-08-12 Sandoz Sa Nouveau compose peptidique et sa preparation
FR2439182A1 (fr) * 1978-10-18 1980-05-16 Sandoz Sa Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
US4388307A (en) * 1978-03-07 1983-06-14 Sandoz Ltd. Galenical compositions

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
US4396542A (en) 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
ATE43335T1 (de) * 1980-02-14 1989-06-15 Sandoz Ag Peptide die einen (1s,2r,3r)- oder (1r,2s,3s)-1nitrilo-1-carbonyl-3-methyl-2-oxyheptan oder hept-5-en-rest enthalten brauchbar in totaler synsthese von cyclosporinen, und verfahren zu ihrer herstellung.
DE3260468D1 (en) 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins
JPS59129920U (ja) * 1983-02-16 1984-08-31 日立造船株式会社 ゲ−ト付バイパスバルブの開閉操作装置
GB8717300D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
FI111730B (fi) 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
ATE158022T1 (de) * 1991-01-25 1997-09-15 Fujisawa Pharmaceutical Co Prozess zur produktion von cyclosporin-a und/oder c
KR100304324B1 (ko) * 1994-10-13 2001-11-22 김용규 사이클로스포린a의제조방법
RU2158601C2 (ru) 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
US6423233B1 (en) 2000-08-15 2002-07-23 Biogal Gyogyszergyar Rt. Purification process
AU2004222306A1 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
US7511013B2 (en) 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
EP1809656A4 (en) 2004-09-29 2009-03-25 Amr Technology Inc CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS
WO2006041631A2 (en) 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
EP2151450A1 (de) * 2008-07-29 2010-02-10 Sandoz AG Verfahren zur Aufarbeitung von mikrobiologisch hergestellten zyklischen Oligopeptiden

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2338251A1 (fr) * 1975-11-04 1977-08-12 Sandoz Sa Nouveau compose peptidique et sa preparation
US4388307A (en) * 1978-03-07 1983-06-14 Sandoz Ltd. Galenical compositions
FR2439182A1 (fr) * 1978-10-18 1980-05-16 Sandoz Sa Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments

Also Published As

Publication number Publication date
CA1030469A (en) 1978-05-02
JPS5615235B2 (xx) 1981-04-09
MY8100203A (en) 1981-12-31
DE2463138C2 (de) 1984-07-05
SE423720B (sv) 1982-05-24
DK136780B (da) 1977-11-21
AU500889B2 (en) 1979-06-07
FI343474A (xx) 1975-06-07
ES432559A1 (es) 1977-03-01
FI52851C (fi) 1977-12-12
DK136780C (xx) 1978-05-01
NZ176117A (en) 1981-05-01
FI52851B (xx) 1977-08-31
SE7415027L (xx) 1975-06-09
AU7608174A (en) 1976-06-10
DE2455859C2 (de) 1983-12-15
IE40549B1 (en) 1979-06-20
IE40549L (en) 1975-06-06
DE2455859A1 (de) 1975-06-12
DD115695A5 (xx) 1975-10-12
NL7415682A (nl) 1975-06-10
FR2253531B1 (xx) 1978-07-21
FI771201A (xx) 1977-04-15
JPS5089598A (xx) 1975-07-18
NL179220B (nl) 1986-03-03
IL46180A (en) 1978-07-31
GB1491509A (en) 1977-11-09
NO744292L (xx) 1975-06-30
IL46180A0 (en) 1975-03-13
NL179220C (nl) 1986-08-01
DK617074A (xx) 1975-07-28
FI54606C (fi) 1979-01-10
FI54606B (fi) 1978-09-29
PH13773A (en) 1980-09-23
HK53880A (en) 1980-10-03

Similar Documents

Publication Publication Date Title
AR201758A1 (xx)
AU476761B2 (xx)
AU465372B2 (xx)
AR201235Q (xx)
AR201231Q (xx)
AU474593B2 (xx)
AU474511B2 (xx)
AU474838B2 (xx)
FR2253531B1 (xx)
AU471343B2 (xx)
AU465453B2 (xx)
AU465434B2 (xx)
AU450229B2 (xx)
AU476714B2 (xx)
AR201229Q (xx)
AU476696B2 (xx)
AU472848B2 (xx)
AU466283B2 (xx)
AR199451A1 (xx)
AU477823B2 (xx)
AR201432A1 (xx)
AR196382A1 (xx)
AU447540B2 (xx)
AR195948A1 (xx)
AR195311A1 (xx)

Legal Events

Date Code Title Description
CL Concession to grant licences
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0082, 920415

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0082, 741205

CL Concession to grant licences